Source: Harvest One
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Harvest One Cannabis (HVT) has signed a supply agreement with Canopy Growth Corporation
  • The agreement enables Harvest One to sell its LivRelief Infused topical creams on Canopy’s Spectrum Therapeutics’ online medical store
  • Under the agreement, Valens will supply Spectrum Therapeutics with Harvest One’s licensed LivRelief Infused products
  • Spectrum Therapeutics offers its patients medical cannabis products from Canopy Growth brands and select partner brands
  • Harvest One is a global cannabis-infused and non-infused CPG company
  • Shares of Harvest One Cannabis Inc. opened trading at $0.04

Harvest One Cannabis (HVT) has signed a supply agreement with Canopy Growth Corporation.

The agreement enables Harvest One to sell its LivRelief Infused topical creams on Canopy’s Spectrum Therapeutics’ online medical store via an extension of its licensing agreement with Valens Agritech Ltd, a wholly-owned subsidiary of The Valens Company.

LivRelief Infused topical creams will be the first Harvest One product sold at the Spectrum Therapeutics store, marking a new distribution milestone for the company.

Under the agreement, Valens will supply Spectrum Therapeutics with Harvest One’s licensed LivRelief Infused products to make them available to patients through Spectrum Therapeutics’ online medical store.

Spectrum Therapeutics offers its patients medical cannabis products from Canopy Growth brands and select partner brands.

“We are very pleased to work with Canopy Growth via our licensing agreement with Valens to distribute Harvest One’s LivRelief Infused brand of topical creams in Spectrum Therapeutics’ online store,” said Gord Davey, President and Chief Executive Officer of Harvest One.

“This is an amazing opportunity for our teams to work together to bring these top-selling infused pain topical creams to more patients,” he added.

“We are dedicated to offering Spectrum Therapeutics patients the widest range of high-quality cannabis products and formats available both from Canopy Growth brands and through agreements with select partner brands like Harvest One,” said Grant Caton, General Manager, Canada, at Canopy.

Harvest One is a global cannabis-infused and non-infused CPG leader that develops and distributes premium health, wellness and self-care products with a market focus on solutions for sleeplessness and pain, resulting in the reduction of fatigue and anxiety.

Shares of Harvest One Cannabis Inc. opened trading at $0.04.

More From The Market Herald

" Potent Ventures (CSE:POT) is now “The Gummy Project Inc.”

Potent Ventures (POT) has received shareholder and CSE approval for its change of business.
Canopy Growth - CEO, David Klein

" Canopy Growth (TSX:WEED) reports Q4 and FY2022 financial results

Canopy Growth Corporation (WEED) has released its financial results for the fourth quarter and fiscal year ended March 31, 2022.